Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety, Dosimetry and Efficacy of 177Lu-FC516 Injection in Patients With Prostate Cancer

NCT07542379 is registered in ClinicalTrials.gov with FindCure Biosciences (ZhongShan) Co., Ltd. as lead sponsor.

NCT NCT07542379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07542379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety, Dosimetry and Efficacy of 177Lu-FC516 Injection in Patients With Prostate Cancer
Lead sponsor
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
August 31, 2026
Completion date
October 31, 2027
Enrollment
13 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer